People: Balchem Corporation (BCPC.O)

BCPC.O on Nasdaq

18.36USD
10:52am EST
Price Change (% chg)

$-0.15 (-0.83%)
Prev Close
$18.51
Open
$18.52
Day's High
$18.85
Day's Low
$18.17
Volume
17,452
Avg. Vol
83,312
52-wk High
$23.17
52-wk Low
$12.48

view people for:

Summary

Name Age Since Current Position
Rossi, Dino 54 2007 Chairman of the Board, President, Chief Executive Officer
Fitzpatrick, Francis 48 2004 Chief Financial Officer, Treasurer, Assistant Secretary
Ludwig, David 51 2000 Vice President, General Manager - Specialty Products
Richardson, Paul 39 2005 Vice President - Research & Development
Houston, Matthew 45 2005 General Counsel, Secretary
Mitchell, Kenneth 69 2005 Lead Director
McMillan, Edward 63 2003 Director
Wedral, Elaine 65 2003 Director
Televantos, John 56 2005 Director
Premdas, Perry 56 2008 Director
» Insider Trading

Biographies

Name Description
Rossi, Dino Mr. Dino A. Rossi has been a Director of Balchem Corporation since 1997 and Chairman of the Company's Board of Directors since February 22, 2007. Mr. Rossi has been President and Chief Executive Officer of the Company since October 1997, Chief Financial Officer of the Company from April 1996 to January 2004 and Treasurer of the Company from June 1996 to June 2003. He was Vice President, Finance and Administration of Norit Americas Inc., a wholly-owned subsidiary of Norit N.V., a Dutch chemicals company, from January 1994 to February 1996, and Vice President, Finance and Administration of Oakite Products Inc., a specialty chemicals company, from 1987 to 1993.
Fitzpatrick, Francis Mr. Francis J. Fitzpatrick, CPA, has been the Chief Financial Officer of Balchem Corporation since January 2004 and Treasurer of the Company since June 2003, and was Controller of the Company from April 1997 to January 2004. He has been an executive officer and Assistant Secretary of the Company since June 1998. He was Director of Financial Operations/Controller of Alliance Pharmaceutical Corp., a pharmaceuticals company, from September 1989 through March 1997.
Ludwig, David Mr. David F. Ludwig has been Vice President and General Manager, Specialty Products of Balchem Corporation since July 1999 and an executive officer of the Company since June 2000. He was Vice President and General Manager of Scott Specialty Gases, a manufacturer of high purity gas products and specialty gas blends, from September 1997 to June 1999. From 1986 to 1997 he held various international and domestic sales and marketing positions with Engelhard Corporation's Pigments and Additives Division.
Richardson, Paul Dr. Paul Richardson, Ph.D., has been Vice President of Research and Development and an Executive Officer of the Company since July 2005, and was Director of Research and Development, January 2004 to July 2005 and Director of Materials Science, January 2001 to January 2004. Since obtaining his Bachelor's degree in chemistry and PhD in polymer science from the University of Durham, England, Dr. Richardson has held Research Scientist and Project Management positions at Unilever Plc. (January 1995 to April 1997) and National Starch and Chemical Company (September 1997 to December 2000).
Houston, Matthew Mr. Matthew D. Houston has been General Counsel of Balchem Corporation since January of 2005 and Secretary, since June of 2005. He was General Counsel and Secretary of Eximias Pharmaceutical Corporation, a privately held corporation, from 2001 to 2004. Mr. Houston also held several internal counsel positions at BASF Corporation, a Delaware corporation from 1994 to 2001. Mr. Houston received his Juris Doctorate from Saint Louis University.
Mitchell, Kenneth Mr. Kenneth P. Mitchell has been Lead Director of Balchem Corporation since October 1, 2005 and has been a Director of the Company since 1993. Mr. Mitchell, who is currently retired, was Chief Executive Officer of Oakite Products Inc., a specialty chemical company from 1986 to 1993. Since February 1997, he has also been a director of Tetra Technologies, Inc., an NYSE traded company, where he also serves as chairman of the Nominating and Corporate Governance Committee.
McMillan, Edward Mr. Edward L. McMillan has been a Director of Balchem Corporation since February 2003. Mr. McMillan owns and manages McMillan, LLC, a transaction-consulting firm that provides strategic consulting services and facilitates mergers and/or acquisitions predominantly to the food and agribusiness industry sectors. From 1988 to 1996, he was President and CEO of Purina Mills, Inc., where he was involved for approximately 25 years in various senior level positions in marketing, strategic planning, and business segment management. Since September 2005, he has been a director of NutraCea, a publicly traded OTC company. In addition, he is also a director of Marical, Inc., a privately held corporation. Mr. McMillan is also a member of the Board of Trustees for the University of Illinois in Champaign, Illinois.
Wedral, Elaine Dr. Elaine R. Wedral has been a Director of Balchem Corporation since October 2003. Dr. Wedral is retired. Currently, she serves as the President of the International Life Sciences Institute in North America, which position she has held since January 2008. She was President of Nestle R&D Center, Inc. in New Milford, Connecticut and Head of Nestle Food Service Systems worldwide from 1999 to 2005. Prior to that, she held a variety of technical positions at Nestle. Dr. Wedral holds 34 patents in food processing, food nutrition and ingredient areas, and is on the editorial board of Food Processing Magazine. She received her Ph.D. from Cornell University in Food Biochemistry, an M.S. in Food Microbiology and a B.S. from Purdue University in Biochemistry. She is currently also a director of Sensient Technologies Corporation, a public company listed on the NYSE, and continues to work with several key industry/university related groups in an advisory capacity.
Televantos, John Dr. John Y. Televantos has been a Director of Balchem Corportion since February 2005. Dr. Televantos is a Principal of Arsenal Capital Partners, Inc., a private equity investment firm, where he leads the Chemicals and Materials practice of the firm. Dr. Televantos was formerly with Hercules, Inc. as President of the Aqualon Division and as Vice President of Hercules, Inc. from April 2002 through February 2005. He had been President and Chief Executive Officer, and prior to that Chief Operating Officer, of Foamex International during the period from June 1999 through December 2001. Prior to that, he was Vice President, Development Businesses and Research at Lyondell Chemical Company since 1998. Dr. Televantos holds B.S. and Ph.D. degrees in Chemical Engineering from the University of London, United Kingdom. He also has been on several public and private company Boards and is affiliated with other key industry-related groups.
Premdas, Perry Mr. Perry W. Premdas was appointed as a Director of Balchem Corporation in January 2008. He is currently retired. From 1999 to 2004, Mr. Premdas was Chief Financial Officer of Celanese AG, a chemical and plastics business spun-off by Hoechst AG and listed on the Frankfurt stock exchange and the NYSE. He was Senior Executive Vice President and Chief Financial Officer of Centeon LLC from 1997 to 1998. Over his 30 year career, he has led the treasury, finance, audit and investor relations functions in US and international companies and had general manager, executive and director roles in various wholly-owned and joint venture operations. Mr. Premdas holds a BA from Brown University and an MBA from the Harvard University Graduate School of Business. He is currently a member of the Board of Directors of Ferro Corporation and Compass Minerals (both listed on the NYSE), and Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ).

Basic Compensation

Name Fiscal Year Total
Rossi, Dino 837,962
Fitzpatrick, Francis 459,897
Ludwig, David 462,459
Richardson, Paul 368,258
Houston, Matthew 259,082
Mitchell, Kenneth --
McMillan, Edward --
Wedral, Elaine --
Televantos, John --
Premdas, Perry --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Rossi, Dino 496,275 5,323,988
Fitzpatrick, Francis 239,063 1,949,224
Ludwig, David 137,250 851,705
Richardson, Paul 66,675 291,703
Houston, Matthew 0 0
Mitchell, Kenneth 0 0
McMillan, Edward 0 0
Wedral, Elaine 0 0
Televantos, John 0 0
Premdas, Perry 0 0

Insider Trading

Name Shares Traded Price
FITZPATRICK FRANCIS J 3,800 $0.07
ROSSI DINO A 7,000 $0.07
HOUSTON MATTHEW DAVID 1,000 $0.00
LUDWIG DAVID F 2,100 $0.07
RICHARDSON PAUL H 2,500 $0.07
TELEVANTOS JOHN Y 3,226 $0.07
PREMDAS PERRY W 3,226 $0.07
WEDRAL ELAINE R 3,226 $0.07
MCMILLAN EDWARD 3,226 $0.07
MITCHELL KENNETH P 3,226 $0.67
FITZPATRICK FRANK P 3,110 $26.87
FITZPATRICK FRANK P 3,110 $6.77
FITZPATRICK FRANK P 22,515 $6.77
FITZPATRICK FRANK P 22,515 $27.21
LUDWIG DAVID F 12,150 $6.83
LUDWIG DAVID F 12,150 $27.45
FITZPATRICK FRANK P 25,000 $6.77
FITZPATRICK FRANK P 25,000 $27.40
ROSSI DINO A 16,875 $1.88
ROSSI DINO A 25,157 $25.11
ROSSI DINO A 25,157 $6.83
ROSSI DINO A 23,440 $6.83
ROSSI DINO A 23,440 $24.41
ROSSI DINO A 18,903 $6.83
ROSSI DINO A 13,341 $23.94
» Full list on Insider Trading
view people for: